It was hypothesized that analysis of the rs11672691 genotypes combined with analysis of PCT19 and CEACAM21 gene expression levels may predict PC recurrence and patient survival, which may be useful in determining further follow-up tactics [42,43,48,49]. This evidence concerns the gene CEACAM21 and pachyonychia congenita.